Aytu BioPharma, Inc. (AYTU)
USD 1.31
(-1.88%)
USD 1.31
(-1.88%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 81 Million | 107.39 Million | 96.66 Million | 65.63 Million | 27.63 Million | 7.32 Million |
| Cost of Revenue | 26.41 Million | 40.76 Million | 44.38 Million | 36.43 Million | 7.55 Million | 2.2 Million |
| Gross Profit | 54.58 Million | 66.63 Million | 52.28 Million | 29.2 Million | 20.07 Million | 5.11 Million |
| Operating Expenses | 59.84 Million | 78.96 Million | 88.38 Million | 67.44 Million | 41.01 Million | 21.96 Million |
| Selling, General and Administrative Expenses | 49.47 Million | 70.07 Million | 69.88 Million | 55.8 Million | 34.8 Million | 19.23 Million |
| Research and Development Expenses | 2.79 Million | 4.09 Million | 14.43 Million | 5.62 Million | 1.72 Million | 589.07 Thousand |
| Other Expenses | 7.57 Million | -4.77 Million | 4.06 Million | 6 Million | 4.49 Million | 2.13 Million |
| Cost and Expenses | 86.25 Million | 119.72 Million | 132.77 Million | 103.87 Million | 48.56 Million | 24.16 Million |
| Operating Income | -5.25 Million | -17.06 Million | 37.21 Million | -38.24 Million | -20.93 Million | -16.84 Million |
| Interest Expense | 4.79 Million | - | 147.49 Million | - | - | - |
| Income Tax Expense | 1.76 Million | -57 Thousand | -110 Thousand | 259 Thousand | -9.92 Million | 20.03 Million |
| Earnings before Tax | -14.07 Million | -17.05 Million | -110.28 Million | -58.03 Million | -13.62 Million | -27.13 Million |
| Net Income | -15.84 Million | -17.05 Million | -108.78 Million | -58.29 Million | -13.62 Million | -47.16 Million |
| Earnings Per Share Basic | -2.86 | -5.11 | -74.01 | -69.60 | -60.20 | -1210.28 |
| Earnings Per Share Diluted | -2.86 | -5.11 | -74.01 | -69.60 | -60.20 | -1210.28 |
| Weighted Average Shares Outstanding | 5.53 Million | 3.34 Million | 1.47 Million | 840 Thousand | 230 Thousand | 38.97 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 5.53 Million | 3.34 Million | 1.47 Million | 840 Thousand | 230 Thousand | 38.97 Thousand |
| Gross Margin | 0.67 | 0.62 | 0.54 | 0.44 | 0.73 | 0.70 |
| EBIT Margin | -0.01 | -0.07 | 0.43 | -0.22 | -0.89 | -0.60 |
| Profit Margin | -0.20 | -0.16 | -1.14 | -0.89 | -0.13 | -6.44 |
| EBITDA | -1.01 Million | -3.51 Million | -27.95 Million | -29.03 Million | -12.2 Million | -14.11 Million |
| Earnings Before Tax Margin | -0.06 | -0.16 | 0.38 | -0.58 | -0.76 | -2.30 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 17.97 Million | 17.99 Million | 22.93 Million | 22.09 Million | 107.39 Million | 30.73 Million |
| Cost of Revenue | 6.07 Million | 6.3 Million | 6.73 Million | 7.31 Million | 40.76 Million | 12.16 Million |
| Gross Profit | 11.9 Million | 11.69 Million | 16.2 Million | 14.78 Million | 66.63 Million | 18.56 Million |
| Operating Expenses | 13.43 Million | 12.61 Million | 12.53 Million | 14.98 Million | 78.96 Million | 15.75 Million |
| Selling, General and Administrative Expenses | 11.08 Million | 11.99 Million | 12.01 Million | 14.37 Million | - | 14.09 Million |
| Research and Development Expenses | 1.04 Million | 619 Thousand | 524 Thousand | 604 Thousand | - | 465 Thousand |
| Other Expenses | 3.65 Million | -1.19 Million | -1.17 Million | -709 Thousand | -4.77 Million | -1.25 Million |
| Cost and Expenses | 19.5 Million | 18.91 Million | 19.27 Million | 22.29 Million | 119.72 Million | 27.92 Million |
| Operating Income | -3.65 Million | -2.46 Million | 2.36 Million | -1.5 Million | -17.06 Million | 169 Thousand |
| Interest Expense | - | - | - | - | - | -2.49 Million |
| Income Tax Expense | 695 Thousand | -245 Thousand | 828 Thousand | -2.23 Million | -57 Thousand | 4.01 Million |
| Earnings before Tax | -3.92 Million | -2.64 Million | 608 Thousand | -8.12 Million | -17.05 Million | -2.45 Million |
| Net Income | -4.62 Million | -2.89 Million | -220 Thousand | -8.12 Million | -17.05 Million | -2.46 Million |
| Earnings Per Share Basic | -0.82 | -0.52 | -0.04 | -1.48 | - | -0.59 |
| Earnings Per Share Diluted | -0.82 | -0.52 | -0.04 | -1.48 | - | -0.59 |
| Weighted Average Shares Outstanding | 5.62 Million | 5.53 Million | 5.52 Million | 5.48 Million | 3.33 Million | 4.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.62 Million | 5.53 Million | 5.52 Million | 5.48 Million | 3.33 Million | 4.05 Million |
| Gross Margin | 0.66 | 0.65 | 0.71 | 0.67 | 0.62 | 0.60 |
| EBIT Margin | -0.26 | -0.14 | 0.10 | -0.07 | - | 0.26 |
| Profit Margin | -0.26 | -0.16 | -0.01 | -0.37 | -0.16 | -0.08 |
| EBITDA | -4.72 Million | -2.46 Million | 2.36 Million | -1.5 Million | - | 8.01 Million |
| Earnings Before Tax Margin | -0.20 | -0.14 | 0.10 | -0.07 | -0.16 | 0.01 |
8413
SNOTF
SUBCY
AJX
CRTD
AVCN